Search

Your search keyword '"AlMadi M"' showing total 92 results

Search Constraints

Start Over You searched for: Author "AlMadi M" Remove constraint Author: "AlMadi M"
92 results on '"AlMadi M"'

Search Results

1. Epidemiology of Pancreatic Cancer in Saudi Arabia: A Retrospective Analysis of Pancreatic Cancer Diagnosed in Saudi Arabia Between 2004 and 2015

2. Predictors of Survival Among Colorectal Cancer Patients in a Low Incidence Area

3. SaudiMEDs and CanMEDs frameworks: similarities and differences

5. Global, regional, and national burden of diseases and injuries for adults 70 years and older: Systematic analysis for the Global Burden of Disease 2019 Study

6. Tools for measuring individual self-care capability: a scoping review

7. P323 The Rate of and Risk of Dysplasia in Long Standing Ulcerative Colitis Patients Among Middle-Eastern Population

8. Five insights from the Global Burden of Disease Study 2019

11. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

12. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study

13. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019:a comprehensive demographic analysis for the Global Burden of Disease Study 2019

14. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

16. CYP19A1 gene polymorphism and colorectal cancer etiology in Saudi population: case–control study

17. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived with Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 : A Systematic Analysis for the Global Burden of Disease Study

20. Pancreatic tuberculosis

21. Systematic review with meta-analysis: placebo rates in induction and maintenance trials of Crohn's disease

28. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

29. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study

30. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

31. Budget impact analysis of subcutaneous infliximab (CT-P13 SC) for treating inflammatory bowel disease in Saudi Arabia: Analysis from payer perspective.

32. The effectiveness of vedolizumab in advanced therapy-experienced ulcerative colitis patients: Real world data from the Inflammatory Bowel Disease of the Middle East (IBD-ME) Registry group.

33. Cost-Consequence Analysis of Colon Cancer Screening among Patients with Long-Standing Ulcerative Colitis: 11 Years' Experience of Saudi Population.

34. Practice guidelines for the management of Helicobacter pylori infection: The Saudi H. pylori Working Group recommendations.

35. Pre-Endoscopic Scores Predicting Low-Risk Patients with Upper Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis.

36. Tools for measuring individual self-care capability: a scoping review.

37. Complementary and alternative medicine use and its association with medication adherence in inflammatory bowel disease and other gastrointestinal diseases.

38. Comparative Evaluation of the ABC Score to Other Risk Stratification Scales in Managing High-risk Patients Presenting With Acute Upper Gastrointestinal Bleeding.

39. The Saudi Gastroenterology Association guidelines for quality indicators in gastrointestinal endoscopic procedures.

40. Topical hemostatic agents in the management of upper gastrointestinal bleeding: a meta-analysis.

41. Informing a cost-effectiveness threshold for Saudi Arabia.

42. Role of the endoscopic Doppler probe in nonvariceal upper gastrointestinal bleeding: Systematic review and meta-analysis.

43. The Long-Term Clinical Effectiveness of Ustekinumab in Antitumor Necrosis Factor-Experienced Crohn's Disease Patients.

44. Do Saudi medical schools consider the core topics in undergraduate medical curricula?

45. Rate and risk factors of postoperative endoscopic recurrence of moderate- to high-risk Crohn's disease patients - A real-world experience from a Middle Eastern cohort.

46. Alkaline conditions can affect the volume and chemical characteristics of dental gutta-percha.

47. Impact of infliximab therapeutic drug level monitoring on outcomes of patients with inflammatory bowel disease: A real-world experience from a Middle Eastern cohort.

48. Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel disease.

49. Recovery of endoscopy services in the era of COVID-19: recommendations from an international Delphi consensus.

50. The cost-effectiveness of biologic versus non-biologic treatments and the health-related quality of life among a sample of patients with inflammatory bowel disease in a tertiary care center in Saudi Arabia.

Catalog

Books, media, physical & digital resources